Home › Trial NCT04713189
Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With Breakthrough Cancer Pain
- Trial IDNCT04713189
- StatusUnknown
- PhasePhase 1/2
- Study typeInterventional
- SponsorLee's Pharmaceutical Limited
- Enrollment96
- Start date2021-03-15
- ConditionsBreakthrough Cancer Pain
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.